• Company
• Trodelvy can be prescribed at general hospitals in KOR
• by Eo, Yun-Ho Jan 8, 2024 06:09am

• Opinion
• [Reporter's View] No regulatory innovation, no future
• by Son, Hyung-Min Jan 8, 2024 06:09am

• Company
• GMP issues causing delays in new drug approval
• by Eo, Yun-Ho Jan 8, 2024 06:08am

• Company
• Roche’s Lunsumio and Columvi win approval in Korea
• by Jan 5, 2024 05:41am

• Company
• Pharma CEOs consider job cuts and reducing hiring in 2024
• by Kim, Jin-Gu Jan 5, 2024 05:41am

• Company
• Koselugo commences prescription with insurance coverage
• by Eo, Yun-Ho Jan 5, 2024 05:41am

• Policy
• Need to specify conditions for postponing PE data submission
• by Lee, Tak-Sun Jan 5, 2024 05:41am

• Company
• Celltrion to divest prescription drugs acquired from Takeda
• by Kim, Jin-Gu Jan 4, 2024 05:33am

• Company
• Industry is less inclined to expand investment this year
• by Kim, Jin-Gu Jan 4, 2024 05:33am

• Policy
• Moderna produced the most drugs in Korea in 2023
• by Lee, Hye-Kyung Jan 4, 2024 05:33am